{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alzheimer\u2019s disease", "Antioxidant", "aggregation", "docking", "neurotoxicity"]], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "27931177", "DateCompleted": {"Year": "2017", "Month": "03", "Day": "09"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"ArticleDate": [], "ELocationID": [], "Language": ["eng"], "Journal": {"ISSN": "1744-5116", "JournalIssue": {"Volume": "55", "Issue": "1", "PubDate": {"Year": "2017", "Month": "Dec"}}, "Title": "Pharmaceutical biology", "ISOAbbreviation": "Pharm Biol"}, "ArticleTitle": "Cholinesterase inhibitory, anti-amyloidogenic and neuroprotective effect of the medicinal plant Grewia tiliaefolia - An in vitro and in silico study.", "Pagination": {"StartPage": "381", "EndPage": "393", "MedlinePgn": "381-393"}, "Abstract": {"AbstractText": ["Grewia tiliaefolia Vahl. (Tiliaceae) is a sub-tropical plant used as an indigenous medicine in India. However, its efficacy has not been evaluated against Alzheimer's disease.", "The objective of this study is to evaluate cholinesterase inhibitory, anti-aggregation and neuroprotective activity of G. tiliaefolia.", "Grewia tiliaefolia leaves were collected from Eastern Ghats region, India, and subjected to successive extraction (petroleum ether, chloroform, ethyl acetate, methanol and water). The extracts were subjected to in vitro antioxidant, anticholinesterase and anti-aggregation assays. The active methanol extract (MEGT) was separated using column chromatography. LC-MS analysis was done and the obtained compounds were docked against acetylcholinesterase (AChE) enzyme to identify the active component.", "Antioxidant assays demonstrated that the MEGT showed significant free radical scavenging activity at the IC<sub>50</sub> value of 71.5\u2009\u00b1\u20091.12\u2009\u03bcg/mL. MEGT also exhibited significant dual cholinesterase inhibition with IC<sub>50</sub> value of 64.26\u2009\u00b1\u20092.56 and 54\u2009\u00b1\u20090.7\u2009\u03bcg/mL for acetyl and butyrylcholinesterase (BChE), respectively. Also, MEGT showed significant anti-aggregation activity by preventing the oligomerization of A\u03b2<sub>25-35</sub>. Further, MEGT increased the viability of Neuro2a cells up to 95% against A\u03b2<sub>25-35</sub> neurotoxicity. LC-MS analysis revealed the presence of 16 compounds including vitexin, ellagic acid, isovitexin, etc. In silico analysis revealed that vitexin binds effectively with AChE through strong hydrogen bonding. These results were further confirmed by evaluating the activity of vitexin in vitro, which showed dual cholinesterase inhibition with IC<sub>50</sub> value of 15.21\u2009\u00b1\u20090.41 and 19.75\u2009\u00b1\u20090.16\u2009\u03bcM for acetyl and butyrlcholinesterase, respectively.", "Grewia tiliaefolia can be considered as a promising therapeutic agent for the treatment of AD."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "a Department of Biotechnology , Alagappa University , Karaikudi , Tamil Nadu , India."}], "LastName": "Sheeja Malar", "ForeName": "Dicson", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "a Department of Biotechnology , Alagappa University , Karaikudi , Tamil Nadu , India."}, {"Identifier": [], "Affiliation": "b Centre for Nanoscience and Nanotechnology , Sathyabama University , Chennai , India."}], "LastName": "Beema Shafreen", "ForeName": "Rajamohamed", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "a Department of Biotechnology , Alagappa University , Karaikudi , Tamil Nadu , India."}], "LastName": "Karutha Pandian", "ForeName": "Shunmugiah", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "a Department of Biotechnology , Alagappa University , Karaikudi , Tamil Nadu , India."}], "LastName": "Pandima Devi", "ForeName": "Kasi", "Initials": "K"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Pharm Biol", "NlmUniqueID": "9812552", "ISSNLinking": "1388-0209"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Amyloid beta-Peptides"}, {"RegistryNumber": "0", "NameOfSubstance": "Cholinesterase Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Free Radical Scavengers"}, {"RegistryNumber": "0", "NameOfSubstance": "Neuroprotective Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Peptide Fragments"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Solvents"}, {"RegistryNumber": "0", "NameOfSubstance": "amyloid beta-protein (25-35)"}, {"RegistryNumber": "7V515PI7F6", "NameOfSubstance": "Apigenin"}, {"RegistryNumber": "9VP70K75OK", "NameOfSubstance": "vitexin"}, {"RegistryNumber": "EC 3.1.1.7", "NameOfSubstance": "Acetylcholinesterase"}, {"RegistryNumber": "EC 3.1.1.8", "NameOfSubstance": "Butyrylcholinesterase"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "Acetylcholinesterase"}, {"QualifierName": ["metabolism"], "DescriptorName": "Amyloid beta-Peptides"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Apigenin"}, {"QualifierName": ["metabolism"], "DescriptorName": "Butyrylcholinesterase"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["isolation & purification", "metabolism", "pharmacology"], "DescriptorName": "Cholinesterase Inhibitors"}, {"QualifierName": [], "DescriptorName": "Chromatography, Liquid"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Free Radical Scavengers"}, {"QualifierName": ["chemistry"], "DescriptorName": "Grewia"}, {"QualifierName": [], "DescriptorName": "Mass Spectrometry"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["drug effects", "metabolism", "pathology"], "DescriptorName": "Neurons"}, {"QualifierName": ["isolation & purification", "metabolism", "pharmacology"], "DescriptorName": "Neuroprotective Agents"}, {"QualifierName": [], "DescriptorName": "Oxidation-Reduction"}, {"QualifierName": ["metabolism"], "DescriptorName": "Peptide Fragments"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["isolation & purification", "metabolism", "pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plant Leaves"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Plaque, Amyloid"}, {"QualifierName": [], "DescriptorName": "Protein Aggregation, Pathological"}, {"QualifierName": [], "DescriptorName": "Protein Binding"}, {"QualifierName": [], "DescriptorName": "Protein Conformation"}, {"QualifierName": ["chemistry"], "DescriptorName": "Solvents"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Abbasi E, Nassiri-Asl M, Sheikhi M, Shafiee M.. 2013. Effects of vitexin on scopolamine-induced memory impairment in rats. Chin J Physiol. 56:184\u2013189.", "ArticleIdList": ["23656220"]}, {"Citation": "Ashani Y, Peggins JO 3rd, Doctor BP.. 1992. Mechanism of inhibition of cholinesterases by huperzine A. Biochem Biophys Res Commun. 184:719\u2013726.", "ArticleIdList": ["1575745"]}, {"Citation": "Badami S, Vijayan P, Mathew N, Chandrashekhar R, Godavarthi A, Dhanaraj SA, Suresh B.. 2003. In vitro cytotoxic properties of Grewia tiliaefolia bark and lupeol. Indian J Pharmacol. 35:250\u2013251."}, {"Citation": "Benzie IF, Strain JJ.. 1996. The ferric reducing ability of plasma (FRAP) as a measure of \u201cantioxidant power\u201d: the FRAP assay. Anal Biochem. 239:70\u201376.", "ArticleIdList": ["8660627"]}, {"Citation": "Blois MS.1958. Antioxidant determinations by the use of a stable free radical. Nature. 181:1199\u20131200."}, {"Citation": "Boada-Rovira M, Brodaty H, Cras P, Baloyannis S, Emre M, Zhang R, Bahra R. 322 Study Group . 2004. Efficacy and safety of donepezil in patients with Alzheimer\u2019s disease: results of a global, multinational, clinical experience study. Drugs Aging. 21:43\u201353.", "ArticleIdList": ["14715043"]}, {"Citation": "Brimson JM, Brimson SJ, Brimson CA, Rakkhitawatthana V, Tencomnao T.. 2012. Rhinacanthus nasutus extracts prevent glutamate and amyloid-\u03b2 neurotoxicity in HT-22 mouse hippocampal cells: possible active compounds include lupeol, stigmasterol and \u03b2-sitosterol. Int J Mol Sci. 13:5074\u20135097.", "ArticleIdList": ["PMC3344267", "22606031"]}, {"Citation": "Butterfield DA, Lauderback CM.. 2002. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress. Free Radic Biol Med. 32:1050\u20131060.", "ArticleIdList": ["12031889"]}, {"Citation": "Chanda S, Dave R.. 2009. In vitro models for antioxidant activity evaluation and some medicinal plants possessing antioxidant properties: an overview. Afr J Microbiol Res. 3:981\u2013996."}, {"Citation": "Clementi ME, Marini S, Coletta M, Orsini F, Giardina B, Misiti F.. 2005. Abeta31\u201335 and Abeta25\u201335 fragments of amyloid beta-protein induce cellular death through apoptotic signals: role of the redox state of methionine-35. FEBS Lett. 579:2913\u20132918.", "ArticleIdList": ["15890345"]}, {"Citation": "Colovi\u0107 MB, Krsti\u0107 DZ, Lazarevi\u0107-Pa\u0161ti TD, Bond\u017ei\u0107 AM, Vasi\u0107 VM.. 2013. Acetylcholinesterase inhibitors: pharmacology and toxicology. Curr Neuropharmacol. 11:315\u2013335.", "ArticleIdList": ["PMC3648782", "24179466"]}, {"Citation": "Corey-Bloom J, Anand R, Veach J.. 1998. A randomized trial evaluating the efficacy and safety of ENA 713 rivastigmine tartrate, a new acetylcholinesterase inhibitor, in patients with mild to moderately severe Alzheimer\u2019s disease. Int J Ger Psychopharmacol. 1:55\u201365."}, {"Citation": "Coyle J, Kershaw P.. 2001. Galantamine, a cholinesterase inhibitor that allosterically modulates nicotinic receptors: effects on the course of Alzheimer's disease. Biol Psychiatry. 49:289\u2013299.", "ArticleIdList": ["11230880"]}, {"Citation": "Ellman GL, Courtney D, Andres V, Feathersto RM.. 1961. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 7:88\u201395.", "ArticleIdList": ["13726518"]}, {"Citation": "Est\u00e9vez AG, Jord\u00e1n J.. 2002. Nitric oxide and superoxide, a deadly cocktail . Ann N Y Acad Sci. 962:207\u2013211.", "ArticleIdList": ["12076976"]}, {"Citation": "Garrat DC.1964. The quantitative analysis of drugs, vol. 3 Japan: Chapman and Hall Ltd; p. 456\u2013458."}, {"Citation": "Hebert LE, Scherr PA, Beckett LA, Albert MS, Pilgrim DM, Chown MJ, Funkenstein HH, Evans DA.. 1995. Age-specific incidence of Alzheimer's disease in a community population. JAMA. 273:1354\u20131359.", "ArticleIdList": ["7715060"]}, {"Citation": "Herraiz T, Chaparro C.. 2006. Human monoamine oxidase enzyme inhibition by coffee and beta-carbolines norharman and harman isolated from coffee. Life Sci. 78:795\u2013802.", "ArticleIdList": ["16139309"]}, {"Citation": "Hiwale S.2015. Sustainable horticulture in semiarid drylands. 1st ed India: Springer (India) Pvt. Ltd; p. 153."}, {"Citation": "Kandale VV, Mujawar SN, Welasly PJ, Nimbalkar JM.. 2013. Development of integrated database of neurodegenerative diseases (IDND). Rev Res. 2:1\u20135."}, {"Citation": "Khadeer-Ahamed MB, Krishna V, Dandin CJ.. 2010. In vitro antioxidant and in vivo prophylactic effects of two gamma-lactones isolated from Grewia tiliaefolia against hepatotoxicity in carbon tetrachloride intoxicated rats. Eur J Pharmacol. 631:42\u201352.", "ArticleIdList": ["20064503"]}, {"Citation": "Knapp MJ, Knopman DS, Solomon PR, Pendlebury WW, Davis CS, Gracon SI.. 1994. A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group. JAMA. 271:985\u2013991.", "ArticleIdList": ["8139083"]}, {"Citation": "Malinski T.2007. Nitric oxide and nitroxidative stress in Alzheimer's disease . J Alzheimers Dis. 11:207\u2013218.", "ArticleIdList": ["17522445"]}, {"Citation": "Matrone C, Brattico E.. 2015. The power of music on Alzheimer\u2019s disease and the need to understand the underlying molecular mechanisms. J Alzheimers Dis Parkinsonism. 5:196. doi: 10.4172/2161-0460.1000196.", "ArticleIdList": ["10.4172/2161-0460.1000196"]}, {"Citation": "Mintzer JE, Kershaw P.. 2003. The efficacy of galantamine in the treatment of Alzheimer's disease: comparison of patients previously treated with acetylcholinesterase inhibitors to patients with no prior exposure. Int J Geriatr Psychiatry. 18:292\u2013297.", "ArticleIdList": ["12673604"]}, {"Citation": "Mohan V, Gibbs AC, Cummings MD, Jaeger EP, DesJarlais RL.. 2005. Docking: successes and challenges. Curr Pharm Des. 11:323\u2013333.", "ArticleIdList": ["15723628"]}, {"Citation": "Mohandas E, Rajmohan V, Raghunath B.. 2009. Neurobiology of Alzheimer's disease. Indian J Psychiatry. 51:55\u201361.", "ArticleIdList": ["PMC2738403", "19742193"]}, {"Citation": "Oyaizu M.1986. Studies on product of browning reaction prepared from glucose amine. Jpn J Nutr. 44:307\u2013315."}, {"Citation": "Patil MV, Patil DA.. 2006. Ethnobotany of Nasik District Maharashtra. New Delhi: Daya Publishing House; p. 183\u2013184"}, {"Citation": "Prasansuklab A, Tencomnao T.. 2013. Amyloidosis in Alzheimer's disease: the toxicity of amyloid beta (A \u03b2), mechanisms of its accumulation and implications of medicinal plants for therapy. Evid Based Complement Alternat Med. 2013:413808. doi: 10.1155/2013/413808.", "ArticleIdList": ["10.1155/2013/413808", "PMC3671299", "23762130"]}, {"Citation": "Sayer R, Law E, Connelly PJ, Breen KC.. 2004. Association of a salivary acetylcholinesterase with Alzheimer's disease and response to cholinesterase inhibitors. Clin Biochem. 37:98\u2013104.", "ArticleIdList": ["14725939"]}, {"Citation": "Schneider LS, Mangialasche F, Andreasen N, Feldman H, Giacobini E, Jones R, Mantua V, Mecocci P, Pani L, Winblad B, et al. . 2014. Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014. J Intern Med. 275:251\u2013283.", "ArticleIdList": ["PMC3956752", "24605808"]}, {"Citation": "Selvam TN, Vengatakrishnan V, Murugesan S, Damodar SK.. 2010. Antioxidant and antiproliferative activity of methanolic extract of Grewia tiliaefolia (Vahl) bark in different cancer cell lines. IJPLS. 1:54\u201360."}, {"Citation": "Shanmugam G, Jayakumar R.. 2004. Structural analysis of amyloid beta peptide fragment (25\u201335) in different microenvironments. Biopolymers. 76:421\u2013434.", "ArticleIdList": ["15468066"]}, {"Citation": "Shaw KP, Aracava Y, Akaike A, Daly JW, Rickett DL, Albuquerque EX.. 1985. The reversible cholinesterase inhibitor physostigmine has channel-blocking and agonist effects on the acetylcholine receptor-ion channel complex. Mol Pharmacol. 28:527\u2013538.", "ArticleIdList": ["2417099"]}, {"Citation": "Singleton VL, Rossi JA.. 1965. Colorimetry of total phenolics with phosphomolybdic-phosphotungstic acid reagents. Am J Enol Vitic. 16:144\u2013158."}, {"Citation": "Suganthy N, Devi KP.. 2016. Protective effect of catechin rich extract of Rhizophora mucronata against \u03b2-amyloid-induced toxicity in PC12 cells. J Appl Biomed. 14:127\u2013146."}, {"Citation": "Syad AN, Devi KP.. 2015. Assessment of anti-amyloidogenic activity of marine red alga G. acerosa against Alzheimer's beta-amyloid peptide 25\u201335. Neurol Res. 37:14\u201322.", "ArticleIdList": ["25016970"]}, {"Citation": "Ullah W, Uddin G, Siddiqui BS.. 2012. Ethnic uses, pharmacological and phytochemical profile of genus Grewia. J Asian Nat Prod Res. 14:186\u2013195.", "ArticleIdList": ["22296161"]}, {"Citation": "Uzar E, Alp H, Cevik MU, F\u0131rat U, Evliyaoglu O, Tufek A, Altun Y.. 2012. Ellagic acid attenuates oxidative stress on brain and sciatic nerve and improves histopathology of brain in streptozotocin-induced diabetic rats. Neurol Sci. 33:567\u2013574.", "ArticleIdList": ["21922312"]}, {"Citation": "Verhoeff NP.2005. Acetylcholinergic neurotransmission and the beta-amyloid cascade: implications for Alzheimer's disease. Expert Rev Neurother. 5:277\u2013284.", "ArticleIdList": ["15853497"]}, {"Citation": "World Alzheimer\u2019s Report 2015 \u2013 The global impact of dementia \u2013 an analysis of prevalence, incidence, cost and trends. October 2015."}], "ReferenceList": []}], "History": [{"Year": "2016", "Month": "12", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "12", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "3", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "12", "Day": "8"}], "PublicationStatus": "ppublish", "ArticleIdList": ["27931177", "PMC6130737", "10.1080/13880209.2016.1241811"]}}], "PubmedBookArticle": []}